Whose intellectual property is Bharat Biotech’s publicly funded Covaxin? India deserves an answer – Scroll.in
- Whose intellectual property is Bharat Biotech’s publicly funded Covaxin? India deserves an answer Scroll.in
- Covishield vs Covaxin: All You Need to Know before Getting the Vaccine Jab News18
- Covaxin: Bharat Biotech seeks DCGI’s nod to extend shelf life to 24 months Mint
- Was public technology let free for private profiteering?: Economist slams high pricing of Covaxin Firstpost
- Call the bluff of vaccine manufacturers: Chidambaram BusinessLine
- View Full coverage on Google News